n n n ‘.concat(e.i18n.t(“search.voice.recognition_retry”),’n
SINGAPORE, Dec. 21, 2023 /PRNewswire/ — Recently, according to multiple reports from local Singaporean media, confirmed cases of COVID-19 are steadily increasing, with the average number of daily hospitalizations on the rise. The virus, once vigorously fought against, seems to be making a comeback, bringing respiratory health issues back into public focus. Faced with the renewed threat of the virus, aside from ensuring the effectiveness of vaccination and practicing mask-wearing for protection, the question arises: Is the commonly used traditional Chinese medicine, especially Lianhua Qingwen Capsules, still a reliable partner in alleviating symptoms and safeguarding respiratory health? The release of the latest international clinical study results may provide some answers.
Findings from this international study were published on November 28, 2023, in the international journal Virology Journal. The study involved 816 patients from 17 hospitals in China, Thailand, Vietnam, the Philippines, and other countries. These patients were diagnosed with mild to moderate COVID-19 according to the World Health Organization’s criteria. In a 1:1 ratio, patients were randomly assigned to the treatment group and the control group. In the treatment group, patients took Lianhua Qingwen Capsules three times a day for 14 consecutive days, with four capsules each time.
https://doi.org/10.1186/s12985-023-02144-6
The effects showed that Lianhua Qingwen’s pill remedy particularly reduced the mean time to improve or relieve COVID-19 symptoms to about four days. The nine most sensitive clinical symptoms included nasal congestion/runny nose, sore throat, cough, shortness of breath, mild weakness/fatigue, muscle aches, headache, chills/chills, and fever.
In addition, the 14-day rate of relief of major COVID-19 symptoms in the Lianhua Qingwen pills treatment group reached 86. 8%, particularly higher than the 71. 9% in the control group. Safety testing did not reveal any reports of severe symptoms. adverse occasions in all matters.
The investigators concluded that treatment with Lianhua Qingwen Capsules could increase the clinical recovery rate, reduce the probability of developing into critical conditions, and demonstrate good safety.
In fact, although they have been widely used in clinical treatments in the past, Lianhua Qingwen pills have been the subject of clinical studies, with more than 120 published articles, more than 60 SCI articles, and a cumulative effect exceeding three hundred points. This study, using foreign criteria of double-blind, multicenter, randomized controlled trials, has once again raised the issue of clinical evidence on the efficacy and protection of Lianhua Qingwen pills.
The investigators also pointed out that the strength of this study lies in recruiting a large sample of patients from four countries in the Western Pacific region, allowing for extrapolation to the Asian population.
According to official information, Lianhua Qingwen Capsules are patented traditional Chinese medicine independently developed and produced by Yiling Pharmaceutical. It was registered and approved for sale in Singapore as a “Chinese patent medicine” in May 2020, and it is available in pharmacies and supermarkets.
As evidence from studies continues to accumulate, classic Chinese medicines, such as Lianhua Qingwen pills, are attracting more and more attention. According to an announcement by Yiling Pharmaceutical, Lianhua Qingwen pills have already been registered and advertised in more than 30 countries and regions around the world.
See the content to download the multimedia:https://www. prnewswire. com/apac/news-releases/international-clinical-trial-results-released-responding-to-the-virus-resurgence-lianhua-qingwen-capsules- provide -noticias-evidencia-302020904. html
SOURCEYiling Pharma